Search Results - "Sebille, A"

Refine Results
  1. 1
  2. 2

    Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome by Secombe, Kate R., Van Sebille, Ysabella Z. A., Mayo, Bronwen J., Coller, Janet K., Gibson, Rachel J., Bowen, Joanne M.

    Published in Integrative Cancer Therapies (2020)
    “…Small molecule receptor tyrosine kinase inhibitors (SM-TKIs) are among a group of targeted cancer therapies, intended to be more specific to cancer cells…”
    Get full text
    Book Review Journal Article
  3. 3

    Dacomitinib‐induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats by Van Sebille, Ysabella Z.A., Gibson, Rachel J., Wardill, Hannah R., Secombe, Kate R., Ball, Imogen A., Keefe, Dorothy M.K., Finnie, John W., Bowen, Joanne M.

    Published in International journal of cancer (15-06-2017)
    “…Dacomitinib—an irreversible pan‐ErbB tyrosine kinase inhibitor (TKI)—causes diarrhoea in 75% of patients. Dacomitinib‐induced diarrhoea has not previously been…”
    Get full text
    Journal Article
  4. 4

    Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer by Wardill, Hannah R., Logan, Richard M., Bowen, Joanne M., Van Sebille, Ysabella Z. A., Gibson, Rachel J.

    Published in Supportive care in cancer (01-04-2016)
    “…Purpose Oral mucositis is one of the most common and debilitating side effects of chemotherapy treatment. Patients are often unable to eat and drink, which can…”
    Get full text
    Journal Article
  5. 5

    Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action by Wardill, H. R., Sonis, S. T., Blijlevens, N. M. A., Van Sebille, Y. Z. A., Ciorba, M. A., Loeffen, E. A. H., Cheng, K. K. F., Bossi, P., Porcello, L., Castillo, D. A., Elad, S., Bowen, J. M.

    Published in Supportive care in cancer (01-11-2020)
    “…Purpose Despite advances in personalizing the efficacy of cancer therapy, our ability to identify patients at risk of severe treatment side effects and provide…”
    Get full text
    Journal Article
  6. 6

    Cytokine‐mediated blood brain barrier disruption as a conduit for cancer/chemotherapy‐associated neurotoxicity and cognitive dysfunction by Wardill, Hannah R., Mander, Kimberley A., Van Sebille, Ysabella Z.A., Gibson, Rachel J., Logan, Richard M., Bowen, Joanne M., Sonis, Stephen T.

    Published in International journal of cancer (15-12-2016)
    “…Neurotoxicity is a common side effect of chemotherapy treatment, with unclear molecular mechanisms. Clinical studies suggest that the most frequent neurotoxic…”
    Get full text
    Journal Article
  7. 7

    Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics by Van Sebille, Ysabella Z. A., Stansborough, Romany, Wardill, Hannah R., Bateman, Emma, Gibson, Rachel J., Keefe, Dorothy M.

    Published in Current Oncology Reports (01-11-2015)
    “…Chemotherapy-induced mucositis is a common condition caused by the breakdown of the mucosal barrier. Symptoms can include pain, vomiting and diarrhoea, which…”
    Get full text
    Journal Article Book Review
  8. 8

    Dacomitinib‐induced diarrhea: Targeting chloride secretion with crofelemer by Van Sebille, Ysabella Z.A., Gibson, Rachel J., Wardill, Hannah R., Ball, Imogen A., Keefe, Dorothy M.K., Bowen, Joanne M.

    Published in International journal of cancer (15-01-2018)
    “…Dacomitinib, an irreversible small‐molecule pan‐ErbB TKI, has a high incidence of diarrhea, which has been suggested to be due to chloride secretory…”
    Get full text
    Journal Article
  9. 9

    Potential safety concerns of TLR4 antagonism with irinotecan: a preclinical observational report by Coller, Janet K., Bowen, Joanne M., Ball, Imogen A., Wardill, Hannah R., van Sebille, Ysabella Z. A., Stansborough, Romany L., Lightwala, Zenab, Wignall, Anthony, Shirren, Joseph, Secombe, Kate, Gibson, Rachel J.

    Published in Cancer chemotherapy and pharmacology (01-02-2017)
    “…Purpose Irinotecan-induced gut toxicity is mediated in part by Toll-Like receptor 4 (TLR4) signalling. The primary purpose of this preclinical study was to…”
    Get full text
    Journal Article
  10. 10

    Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms by Wardill, Hannah R, Gibson, Rachel J, Van Sebille, Ysabella Z A, Secombe, Kate R, Coller, Janet K, White, Imogen A, Manavis, Jim, Hutchinson, Mark R, Staikopoulos, Vasiliki, Logan, Richard M, Bowen, Joanne M

    Published in Molecular cancer therapeutics (01-06-2016)
    “…Strong epidemiological data indicate that chemotherapy-induced gut toxicity and pain occur in parallel, indicating common underlying mechanisms. We have…”
    Get full text
    Journal Article
  11. 11

    ErbB small molecule tyrosine kinase inhibitor (TKI) induced diarrhoea: Chloride secretion as a mechanistic hypothesis by Van Sebille, Ysabella Z.A, Gibson, Rachel J, Wardill, Hannah R, Bowen, Joanne M

    Published in Cancer treatment reviews (01-07-2015)
    “…Highlights • The mechanisms of ErbB TKI-induced diarrhoea are likely different to chemotherapy. • This paper provides rationale for chloride secretion as a…”
    Get full text
    Journal Article
  12. 12

    Time course study of the isometric contractile properties of mdx mouse striated muscles by PASTORET, C, SEBILLE, A

    “…The isometric twitch and tetanic contractions of three hindlimb muscles (soleus, plantaris, extensor digitorum longus) were recorded in situ in groups of mdx…”
    Get full text
    Journal Article
  13. 13

    Prophylactic probiotics for cancer therapy-induced diarrhoea: a meta-analysis by Wardill, Hannah R., Van Sebille, Ysabella Z.A., Ciorba, Matthew A., Bowen, Joanne M.

    “…PURPOSE OF REVIEWStrong preclinical data support prophylactic probiotics as an effective preventive strategy for diarrhoea secondary to anticancer therapies…”
    Get full text
    Journal Article
  14. 14

    TLR4-Dependent Claudin-1 Internalization and Secretagogue-Mediated Chloride Secretion Regulate Irinotecan-Induced Diarrhea by Wardill, Hannah R, Bowen, Joanne M, Van Sebille, Ysabella Z A, Secombe, Kate R, Coller, Janet K, Ball, Imogen A, Logan, Richard M, Gibson, Rachel J

    Published in Molecular cancer therapeutics (01-11-2016)
    “…We have previously shown increased intestinal permeability, to 4-kDa FITC-dextran, in BALB/c mice treated with irinotecan. Importantly, genetic deletion of…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Highlight article: Use of zebrafish to model chemotherapy and targeted therapy gastrointestinal toxicity by Van Sebille, Ysabella ZA, Gibson, Rachel J, Wardill, Hannah R, Carney, Thomas J, Bowen, Joanne M

    “…Gastrointestinal toxicity arising from cancer treatment remains a key reason for treatment discontinuation, significantly compromising remission. There are…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Factors inducing mast cell accumulation in skeletal muscle by Lefaucheur, J P, Gjata, B, Sebille, A

    Published in Neuropathology and applied neurobiology (01-06-1996)
    “…It has been suggested that mast cells contribute to the phenotype of dystrophinopathies, but the mechanisms of their recruitment into the skeletal muscle…”
    Get more information
    Journal Article
  20. 20

    Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity by Wardill, Hannah R, Van Sebille, Ysabella Z A, Mander, Kimberley A, Gibson, Rachel J, Logan, Richard M, Bowen, Joanne M, Sonis, Stephen T

    Published in Cancer treatment reviews (01-02-2015)
    “…Regimen-related toxicities remain a priority concern within the field of supportive care in cancer. Despite this, many forms of toxicity are under reported and…”
    Get full text
    Journal Article